Wantstats
Company ProfilePremium

CHIESI Farmaceutici SpA

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
CHIESI Farmaceutici SpA - Healthcare showcase

Year Founded & Workforce

1935

5,624 Employees

Industry

Healthcare

Services

Respiratory
C

CHIESI Farmaceutici SpA Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

CHIESI Farmaceutici SpA Overview

Company Headquarters: Parma, Italy

Founded: 1935

Workforce: ~5624

Company Working: CHIESI Farmaceutici SpA (Chiesi) is an international research-focused Healthcare Group. Chiesi mainly focuses on the research, development, and marketing of the innovative drugs in respiratory therapeutics, specialty medicine, and rare disease areas. Chiesi group has more than 80 years of experience in the pharmaceutical industry. The company has its presence in 26 countries. The company has its research and development organization in Pharma. However, it is integrated with six other R&D groups in France, the US, the UK, Sweden, and Denmark.

Strategy

Chiesi is recognized as an international group that is focused towards research. It develops and markets innovative therapeutic market solutions that can meet the unmet medical needs.

Company Snapshot

$1,671.3M

Revenue

5,624

Employees

1935

Founded

Parma, Italy

Headquarters

SWOT Analysis

Strengths

  • Strong position in the European market
  • Skilled workforce

Weaknesses

  • Limited product portfolio

Opportunities

  • Expansion in untapped market

Threats

  • Stringent government rules

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
November 2016AcquisitionChiesi acquires Atopix therapeutics. The acquisition of the UK-based clinical-stage biotechnology company enhanced Chiesi’s Asthma Segment.

Product Offering

  • CHIESI Farmaceutici SpA
    • Respiratory

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 1,671.3 Mn in 2016 to USD 2,084.9 Mn in 2018.
CHIESI Farmaceutici SpA — By Business Segment
Series (USD Mn)201620172018
Sales1,671.31,825.62,084.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →